| Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL) RE Nappi, L Cucinella, S Martella, M Rossi, L Tiranini, E Martini Maturitas 94, 87-91, 2016 | 333 | 2016 |
| Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women RE Nappi, E Martini, L Cucinella, S Martella, L Tiranini, A Inzoli, ... Frontiers in endocrinology 10, 561, 2019 | 139 | 2019 |
| Sexuality in premature ovarian insufficiency RE Nappi, L Cucinella, E Martini, M Rossi, L Tiranini, S Martella, D Bosoni, ... Climacteric 22 (3), 289-295, 2019 | 50 | 2019 |
| Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome L Tiranini, RE Nappi Faculty reviews 11, 2022 | 42 | 2022 |
| Role of estrogens in menstrual migraine RE Nappi, L Tiranini, S Sacco, E De Matteis, R De Icco, C Tassorelli Cells 11 (8), 1355, 2022 | 39 | 2022 |
| Medical treatment of female sexual dysfunction RE Nappi, L Tiranini, E Martini, D Bosoni, A Righi, L Cucinella Urologic Clinics 49 (2), 299-307, 2022 | 21 | 2022 |
| The sexuological impact of hormonal contraceptives based on their route of administration M Guida, C Di Carlo, J Troisi, A Gallo, F Cibarelli, E Martini, L Tiranini, ... Gynecological Endocrinology 33 (3), 218-222, 2017 | 19 | 2017 |
| Premenstrual syndrome and premenstrual dysphoric disorder as centrally based disorders RE Nappi, L Cucinella, D Bosoni, A Righi, F Battista, P Molinaro, ... Endocrines 3 (1), 127-138, 2022 | 13 | 2022 |
| Perimenstrual asthma in adolescents: a shared condition in pediatric and gynecological endocrinology V Calcaterra, RE Nappi, A Farolfi, L Tiranini, V Rossi, C Regalbuto, ... Children 9 (2), 233, 2022 | 10 | 2022 |
| Polycystic ovary syndrome and sexuality RE Nappi, L Tiranini Gynecological Endocrinology 38 (7), 535-536, 2022 | 7 | 2022 |
| Menopause and female sexual dysfunctions. L Cucinella, E Martini, L Tiranini, F Battista, P Molinaro, A Casiraghi, ... Minerva Obstetrics and Gynecology 74 (3), 234-248, 2022 | 7 | 2022 |
| Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics? RE Nappi, L Cucinella, L Tiranini, E Martini Expert Opinion on Pharmacotherapy 19 (5), 421-423, 2018 | 6 | 2018 |
| Different local estrogen therapies for a tailored approach to GSM RE Nappi, L Tiranini, E Martini, D Bosoni, C Cassani, L Cucinella Climacteric 26 (4), 361-366, 2023 | 5 | 2023 |
| Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? RE Nappi, L Tiranini, L Cucinella, E Martini, D Bosoni, A Righi, C Cassani, ... Expert Opinion on Pharmacotherapy 24 (1), 135-143, 2023 | 5 | 2023 |
| Genitourinary syndrome of menopause: should we treat symptoms or signs? L Cucinella, E Martini, L Tiranini, P Molinaro, F Battista, RE Nappi Current Opinion in Endocrine and Metabolic Research 26, 100386, 2022 | 5 | 2022 |
| Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women. Front Endocrinol 10: 561 RE Nappi, E Martini, L Cucinella, S Martella, L Tiranini, A Inzoli, ... | 5 | 2019 |
| Genitourinary syndrome of menopause in breast cancer survivors: current perspectives on the role of laser therapy L Cucinella, L Tiranini, C Cassani, S Martella, RE Nappi International Journal of Women's Health, 1261-1282, 2023 | 4 | 2023 |
| Women’s attitudes about combined hormonal contraception (CHC)-induced menstrual bleeding changes-influence of personality traits in an Italian clinical sample RE Nappi, L Tiranini, D Bosoni, L Cucinella, M Piccinino, A Cumetti, ... Gynecological Endocrinology 39 (1), 2189971, 2023 | 4 | 2023 |
| Relationship between personality traits and sexual function in symptomatic postmenopausal women F Barbagallo, L Cucinella, L Tiranini, E Martini, D Bosoni, P Molinaro, ... Maturitas 166, 50-57, 2022 | 3 | 2022 |
| “50 Shades of sex” under hormonal contraception RE Nappi, L Tiranini Gynecological Endocrinology 36 (9), 753-754, 2020 | 3 | 2020 |
